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Enhanced Basal Autophagy Supports Ameloblastoma-Derived Cell Survival and
Reactivation
Abstract
Objectives: Ameloblastoma is an aggressive odontogenic jaw neoplasm. Its unlimited growth confers
high potential for malignant transformation and recurrence. It is unclear why ameloblastoma is highly
recurrent despite surgical resection with a wide margin of normal tissue. While canonical autophagy can
be used to degrade and eliminate damaged cellular components, it is also a protective mechanism that
provides energy and vital metabolites for cell survival. We used ameloblastoma-derived cells to test the
hypothesis that autophagic processes play a role in survival and reactivation of ameloblastoma. Methods:
Primary epithelial (EP-AMCs) and mesenchymal (MS-AMCs) ameloblastoma-derived cells were
established from tissue samples of solid multicystic ameloblastoma. Clonogenic capacity and basal
autophagic capacity were assessed in ameloblastoma-derived cells relative to human odontoma-derived
cells (HODCs) and maxilla-mesenchymal stem cells (MX-MSCs). Ability of ameloblastoma-derived cells to
survive and form new ameloblastoma was assessed in mouse tumor xenografts. Results: EP-AMCs were
highly clonogenic (p < 0.0001) and demonstrated enhanced basal levels of autophagic proteins
microtubule-associated protein 1-light chain 3 (LC3) (p < 0.01), p62 (Sequestosome 1, SQSTM1) (p <
0.01), and the LC3-adapter, melanoregulin (MREG) (p < 0.05) relative to controls. EP-AMCs xenografts
regenerated solid ameloblastoma-like tumor with histological features of columnar ameloblast-like cells,
loose stellate reticulum-like cells and regions of cystic degeneration characteristic of follicular variant of
solid multicystic ameloblastoma. The xenografts also displayed stromal epithelial invaginations strongly
reactive to LC3 and p62 suggestive of epithelial-mesenchymal transition and neoplastic odontogenic
epithelium. Conclusions: EP-AMCs exhibit altered autophagic processes that can support survival and
recurrence of post-surgical ameloblastoma cells. © 2018 Elsevier Ltd
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Enhanced basal autophagy supports ameloblastoma-derived cell survival
and reactivation
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Objectives: Ameloblastoma is an aggressive odontogenic jaw neoplasm. Its unlimited growth confers high potential for malignant transformation and recurrence. It is unclear why ameloblastoma is highly recurrent despite
surgical resection with a wide margin of normal tissue. While canonical autophagy can be used to degrade and
eliminate damaged cellular components, it is also a protective mechanism that provides energy and vital metabolites for cell survival. We used ameloblastoma-derived cells to test the hypothesis that autophagic processes
play a role in survival and reactivation of ameloblastoma.
Methods: Primary epithelial (EP-AMCs) and mesenchymal (MS-AMCs) ameloblastoma-derived cells were established from tissue samples of solid multicystic ameloblastoma. Clonogenic capacity and basal autophagic
capacity were assessed in ameloblastoma-derived cells relative to human odontoma-derived cells (HODCs) and
maxilla-mesenchymal stem cells (MX-MSCs). Ability of ameloblastoma-derived cells to survive and form new
ameloblastoma was assessed in mouse tumor xenografts.
Results: EP-AMCs were highly clonogenic (p < 0.0001) and demonstrated enhanced basal levels of autophagic
proteins microtubule-associated protein 1-light chain 3 (LC3) (p < 0.01), p62 (Sequestosome 1, SQSTM1)
(p < 0.01), and the LC3-adapter, melanoregulin (MREG) (p < 0.05) relative to controls. EP-AMCs xenografts
regenerated solid ameloblastoma-like tumor with histological features of columnar ameloblast-like cells, loose
stellate reticulum-like cells and regions of cystic degeneration characteristic of follicular variant of solid multicystic ameloblastoma. The xenografts also displayed stromal epithelial invaginations strongly reactive to LC3
and p62 suggestive of epithelial-mesenchymal transition and neoplastic odontogenic epithelium.
Conclusions: EP-AMCs exhibit altered autophagic processes that can support survival and recurrence of postsurgical ameloblastoma cells.

1. Introduction
Ameloblastoma is the most common odontogenic tumor in subSaharan Africa (Ogundana, Eﬃom, & Odukoya, 2017) while odontoma
formerly regarded as a dental harmatomatous tissue (El-Naggar, 2017)
is the most common odontogenic tumor among Caucasians. However,
ameloblastoma is the most aggressive of all odontogenic tumors
(Bassey, Osunde, & Anyanechi, 2014). Ameloblastoma arises from
odontogenic epithelium within a mature ﬁbrous stroma that is devoid
of odontogenic ectomesenchyme (Sciubba, Eversole, & Slootweg,
2005). The unlimited growth of ameloblastoma confers a high potential

for malignant transformation, metastasis and recurrence (DeVilliers,
Suggs, Simmons, Murrah, & Wright, 2011; McClary et al., 2016).
Management of ameloblastoma is surgical resection with a wide margin
of surrounding normal tissue. Radical surgery causes signiﬁcant morbidity, disﬁgurement and tumor recurrence that can range from 50 to
70% (Dandriyal, Gupta, Pant, & Baweja, 2011; Ghandhi et al., 2006;
Laborde, Nicot, Wojcik, Ferri, & Raoul, 2017). Unfortunately, nonsurgical conservative therapy is associated with a higher recurrence of
90% (Laborde et al., 2017). It is unclear why ameloblastomas are highly
recurrent despite surgical resection that includes a wide margin of
surrounding normal tissue. It is possible that invasive ameloblastoma
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suspension in a T-75 ﬂask of Keratinocyte Growth Medium KGM-Gold™
(Catalogue #:192151, Allendale NJ), 2 mM glutamine, 100U/ml penicillin, 100 μg/ml streptomycin sulfate, 100 μM L-ascorbate-2-phosphate
and 10% fetal bovine serum. The remaining single cell suspension was
seeded in T-75 ﬂask containing α-MEM, 2 mM glutamine, 100U/ml
penicillin, 100 μg/ml streptomycin sulfate, 100 μM L-ascorbate-2-phosphate and 10% fetal bovine serum to establish mesenchymal ameloblastoma-derived cells (MS-AMCs). Both cell types were maintained in a
humidiﬁed incubator at 37 °C and 5% CO2. The culture media were
changed every three days. At 75% conﬂuence, primary cells were detached with 0.25% trypsin/EDTA (Thermo-Fisher Invitrogen, Waltham
MA) and sub-cultured so that both primary and passage 1 cells were
stored in liquid nitrogen. For all experiments, early passages 3–5 cells
were tested. Previously described human odontoma-derived cells
(HODCs) (Song, Stefanik, Damek-Poprawa, Alawi, & Akintoye, 2009)
and ameloblast-lineage cells (ALCs) [courtesy of Drs. Caroline Gibson
and Sugiyama] served as odontogenic controls while maxillary mesenchymal stem cells (MX-MSCs) (Akintoye et al., 2006) served as nonodontogenic control.

cells at the surgical margin predispose to surgical ‘tumor cell seeding’
that eventually reactivate to induce recurrence (Arotiba et al., 2012).
Most ameloblastomas display genetic mutations of BRAF that encodes
the serine/threonine protein kinase B-Raf, an activator of MAPK/ERKsignaling pathway as well as mutations of SMO (Smoothened) a component of the hedgehog signaling pathway (Eﬃom, Ogundana,
Akinshipo, & Akintoye, 2017; Sweeney et al., 2014). Additionally,
ameloblastoma neoplastic cells express high levels of autophagic markers LC3 (microtubule associated protein 1 light chain 3), p62 (sequestosome 1 [SQSTM1]), and ATG7 (autophagy related 7) which
suggests that autophagic process may play a role in the neoplastic microenvironmental processes within ameloblastoma (Okada et al.,
2014). As BRAF oncogenes induce the expression of key autophagic
markers that include LC3, p62 and BECN1 (Beclin1), and ameloblastomas demonstrate a high frequency of the oncogenic BRAF V600E
mutation similar to colorectal cancer cells (Goulielmaki et al., 2016), it
is possible that recurrence of ameloblastoma is activated by autophagic
cell survival mechanisms of residual post-surgical marginal tumor cells.
Since ameloblastoma and odontoma are the most common odontogenic
tumors and ameloblastoma displays locally-aggressive growth unlike
odontoma, we tested the hypothesis that autophagic process is disproportionately activated in ameloblastoma-associated odontogenic
cells to support recurrence relative to the non-aggressive odontomaassociated odontogenic cells. Our goal is to further understand the
mechanistic cues that induce ameloblastoma recurrence.

2.3. Colony forming eﬃciency
Primary EP-AMCs, MS-AMCs and MX-MSCs were sub-cultured at
102, 103, 104 and 105 cells per ﬂask in triplicate T-25 ﬂasks using
growth medium of KGM and α-MEM respectively as described above. At
14 days, cells were ﬁxed with 100% methanol, stained with methyl
violet solution and colonies of 50 or more cell aggregates were counted
to calculate colony forming eﬃciency (CFE).

2. Methods
2.1. Tissue processing

2.4. Immunostaining for autophagic markers
Fresh ameloblastoma tissues were collected from a gross surgical
sample of ameloblastoma. This study was approved by Lagos University
Teaching Hospital Health Research Ethics committee protocol # 2205
and University of Pennsylvania Oﬃce of Regulatory Aﬀairs Institutional
Review Board (IRB) protocol # 829,501. A representative portion of the
fresh surgical tissue sample was ﬁxed in buﬀered formalin and 5 μm
sections were stained with hematoxylin-eosin for microscopic analysis.
Two board-certiﬁed oral pathologists conﬁrmed a diagnosis of solid
multicystic ameloblastoma-follicular pattern (SMA-f) based on current
World Health Organization histological classiﬁcation of odontogenic
tumors (Eﬃom et al., 2017; Wright, Odell, Speight, & Takata, 2014).
Another representative portion of the ameloblastoma surgical sample
was processed for culture and establishment of primary ameloblastomaderived cells.

The diﬀerent cell populations (EP-AMCs, MS-AMCs, HODCs, ALC
and MX-MSCs) were cultured at low density in collagen-coated 35 mm
dishes (No. 1.5 Coverslip, 10 mm Glass Diameter; catalogue #
P35GCOL-1.5-10-C, MatTek, Ashland, MA). At 60–70% conﬂuence,
cells were ﬁxed with 4% paraformaldehyde for 10 min followed by
immunostaining with rabbit anti-LC3B (1:100, #2775S, Cell Signaling
Technology, Danvers MA), and guinea pig anti-p62 / SQSTM1 (1:50,
GP62-C, Progen) as previously described (Reyes-Reveles et al., 2017).
Brieﬂy, the samples were blocked in blocking solution containing 5%
BSA and 0.2% Triton X-100 in PBS (PBST) at 37 °C for 1 h, incubated
with primary antibody diluted in blocking solution at 4 °C overnight,
washed and incubated with appropriate secondary antibody (goat antirabbit Alexa Fluor 594 or goat anti-guinea pig Alexa Fluor 488 conjugates (Invitrogen). For negative control cells, the primary antibodies
were substituted with non-immune sera. Images were acquired with the
same laser settings using Nikon A1R laser scanning confocal microscope
with a PLAN APO VC 60x water (NA 1.2) objective at 18 °C and Nikon
Elements AR 4.30.01 software.

2.2. Establishment of ameloblastoma-derived cells
Ameloblastoma-derived cells were isolated using an established
protocol for isolation of human orofacial mesenchymal stem cells
(OFMSCs) (Akintoye et al., 2006). Described brieﬂy, fresh ameloblastoma tissue collected in cold α-modiﬁed Minimum Essential
Medium (α -MEM, Catalogue # 11095072, Thermo-Fisher Invitrogen,
Waltham MA) was processed under aseptic conditions within 48 h of
collection. Loose soft tissues on the external surface of ameloblastoma
sample were carefully cleaned with sterile surgical blade and washed
three times in phosphate-buﬀered saline (PBS). The sample was cut in
tiny fragments with sharp surgical scissors in a reaction vial containing
ice cold α-MEM followed by digestion with 1:1 collagenase-type I
(3 mg/ml) and dispase (4 mg/ml) for 1 h at 37 °C as previously reported
(Jiang et al., 2017). The cell suspension was passed through a 70 μm
nylon cell strainer (Catalogue # 352350, BD Biosciences Discovery
Labware, San Jose, CA) to release single cells, split into two equal volumes and then washed twice in PBS plus centrifugation at 1500 rpm for
5 min. Both epithelial and mesenchymal-derived primary cell lines were
cultured. The primary epithelial ameloblastoma-derived cells (EPAMCs) were established by seeding one half of the single cell

2.5. Assessment of basal level autophagic proteins by western blotting
Lysates of EP-AMCs, MS-AMCs, HODCs, MX-MSCs and ALC were
prepared in RIPA buﬀer (Cat # R0278; MilliporeSigma, St Louis MO)
supplemented with 1% protease inhibitor cocktail (Cat # P8340;
MilliporeSigma, St Louis MO) and 2% phosphatase inhibitor cocktail 2
(Cat # P5726; MilliporeSigma, St Louis MO). Total protein amount was
determined using bicinchoninic acid protein assay (Cat # 23,225;
Thermo Scientiﬁc Waltham MA) and 15 μg protein per sample was separated under reducing condition in a 12% Bis-Tris polyacrylamide gel
electrophoresis (Cat # NP 0341; Invitrogen-Thermo Scientiﬁc, Waltham
MA). The protein bands were transferred to a PVDF membrane (Cat #
IPVH00010, Millipore, Billerica, MA) blocked with 5% milk buﬀer (5%
milk in PBS, 0.1% Tween-20) for 1 h at room temperature and incubated with the following primary antibodies: anti-p62 (1:1000; Cat #
PM045, MBL International, Woburn MA), anti-LC3B (1:1500; Cat #
62
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3868S Cell Signaling Technology, Danvers MA,), anti-melanoregulin
(MREG) (1:500; Cat # H00055686-D01 P, Abnova, Walnut CA) and
anti-β-actin (1:500; Cat # A2228 MilliporeSigma, St Louis MO) served
as loading control. The membranes were washed three times before
incubating for 1 h at room temperature with either goat anti-rabbit
(1:2500; Cat # 31,462 Thermo-Fisher Scientiﬁc, Waltham MA) or goat
anti-mouse (1:3000 Cat # 32430, Thermo-Fisher Scientiﬁc, Waltham
MA) secondary antibodies conjugated to horseradish peroxidase. The
signals were developed using ECL SuperSignal® West Dura extended
duration substrate (Cat # 34075, Thermo-Fisher Scientiﬁc, Waltham
MA) and captured on Odyssey® Fc analyzed with ImageStudio™ software (version 5.2) (LI−COR, Lincoln NE).

2.6. Mouse xenograft model of ameloblastoma
The animal protocol (# 806,165) was approved by the University of
Pennsylvania Institutional Animal Use and Care Committee. After ex
vivo expansion of EP-AMCs, MS-AMCs, HODCs, MX-MSCs and ALCs,
2 × 106 cells of each type were attached to 40 mg of spheroidal hydroxyapatite/tricalcium phosphate (HA/TCP, particle size 0.5–1.0 mm,
Zimmer, Warsaw, IN) before transplantation into separate subcutaneous pockets of 4-week-old immunocompromised nude female
mice (Charles River Laboratories, Wilmington, MA). Each mouse received four grafts of randomly selected cell type so that every mouse
harbored graft from at least three diﬀerent cell types. The grafts were
harvested by week 4, ﬁxed in 4% paraformaldehyde in PBS (pH 7.4),
decalciﬁed in 10% EDTA (pH 8.0) and embedded in paraﬃn. Four
diﬀerent 5 μm sections were stained with hematoxylin/eosin (H&E) for
histological evaluation.

Fig. 1. EP-AMCs highly clonogenic. EP-AMSCs display signiﬁcantly high
colony forming units (CFUs) relative to maxillary mesenchymal stem cells (MXMSCs) (p < 0.0001).

3. Results
3.1. Ameloblastoma harbors abundant subpopulation of highly clonogenic
cells

2.7. Immunohistochemical assessment of ameloblastoma xenograft

Starting with fresh tissues of SMA-f, we successfully isolated the
characteristic round, polygonal epithelial-derived (EP-AMCs) and
spindle shaped mesenchymal-derived (MS-AMCs) ameloblastoma cells.
Interestingly, the EP-AMCs were signiﬁcantly more clonogenic
(p < 0.0001) compared with normal maxillary mesenchymal cells
(MX-MSCs) (Fig. 1) while clonogenic capacity of MS-AMCs and MXMSCs were similar (data not shown). These results suggest that local
aggressiveness of ameloblastoma and reactivation of residual cells may
be related to the stem cell-like proliferative properties of EP-AMCs.

Xenograft tissue sections were deparaﬃnized, rehydrated, blocked
with 3% hydrogen peroxide followed by 1-hour steaming in citrate
buﬀer for antigen retrieval. Tissue sections were rinsed in water,
blocked for 40 min in 2.5% normal horse serum (Cat # S-2012, Vector
Laboratories, Burlingame CA) and immunostained with primary antibodies to p62 (1:1000; Cat # PM045, MBL International, Woburn MA)
and LC3 (1:1500; Cat #3868S, Cell Signaling Technology, Danvers MA)
overnight at 4 °C. Tissue sections were rinsed in PBS before incubating
for 30 min in ImmPRESS™ HRP goat anti-rabbit IgG (peroxidase)
polymer detection reagent (Cat # MP-7451, Vector Laboratories,
Burlingame CA), stained with DAB peroxidase substrate solution (Cat #
SK 4105, Vector Laboratories, Burlingame CA), and counterstained with
hematoxylin. Images were evaluated microscopically and captured with
Nikon Eclipse 80i (Nikon Instruments, Melville, NJ) equipped with
SPOT Flex digital camera (Diagnostic Instruments, Sterling Heights,
MI).

3.2. EP-AMCs accumulate LC3 and p62
Although several autophagy-related proteins have been identiﬁed in
diﬀerent variants of ameloblastoma, the role of autophagy in ameloblastoma aggressiveness is unclear. EP-AMCs (Fig. 2; red, LC3B [A];
green, p62 [B] and merge, [C]) and ALCs (Fig. 2H–J), another epithelial-derived ameloblast lineage cells displayed enhanced LC3-puncta as
compared to HODCs, a mesenchymal-derived odontogenic cell population (Fig. 2D–F) and non-odontogenic cells, MX-MSCs (Fig. 2G–I).
SQSTRM (p62) puncta were also elevated in the EP-AMCs and ALCs
(Fig. 2J–K) that suggest impaired autophagosome degradation (Mathew
et al., 2009). LC3B is one of three isoforms of LC3. After cleavage at the
carboxy terminus, LC3 is converted to LC3I and autophagic processing
converts LC3I to the lipidated form, LC3II. Immunoblots showed that
both LC3II (p < 0.01) and p62 (p < 0.01) were the strongest EP-AMC
immunoreactive bands relative to MS-AMCs associated with ameloblastoma stroma and control odontogenic and non-odontogenic cells
(Fig. 3). The levels of MREG (p < 0.05), an LC3B binding partner
necessary for cargo degradation in LC3-associated phagocytosis (Frost
et al., 2015) was also strongly enhanced in EP-AMCs suggesting dysregulation of selective autophagic degradation process in EP-AMCs
(Fig. 3).

2.8. Statistical analysis
The ameloblast-derived cells were seeded in triplicate ﬂasks with
appropriate parallel sets of odontogenic and non-odontogenic controls.
All animal transplants were performed using triplicate animals and
each animal received 3–4 grafts to minimize individual animal variability. All data were expressed as mean ± standard deviation.
Diﬀerences between ameloblast-derived cells and controls were assessed with one-way analysis of variance (ANOVA) followed by post
hoc comparisons with Turkey–Kramer test. Statistical signiﬁcance was
set at P < 0.05.

63
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Fig. 2. Enhanced autophagy in EP-AMCs. Confocal immunoﬂuorescent images of EP-AMCs (A–C) show strong expression of LC3 and p62 (A, red, Alexa Fluor
594–labeled-anti-LC3B; B, green, Alexa Fluor 488-labelled anti-p62 and C, merge). Relatively lower reactivity was displayed in merged images of positive control
odontogenic cells (D, ALCs; E, HODCs) and negative control non-odontogenic cells (F, MX-MSCs). Nuclei stained blue with Hoechst. [EP-AMCs = epithelial ameloblastoma cells; ALCs = mouse ameloblast lineage cells; HODCs = human odontoma-derived cells; MX-MSCs = maxillary mesenchymal stem cells].

and found EP-AMCs to be the signiﬁcantly clonogenic sub-population.
Abundance of cancer-stem cells have been identiﬁed in several cancers
including head and neck cancers (Almeida, Guimaraes, Squarize, &
Castilho, 2016). Speciﬁcally, an enriched amount of stem cell-related
genes has been demonstrated in ameloblastoma stroma (Jiang et al.,
2017). Taken together, these suggest that putative sub-population of
stem cells reside in ameloblastoma that possibly support odontogenic
epithelial proliferations characteristic of ameloblastoma (Eﬃom et al.,
2017). Since stem cell-like increase in clonogenic index is a common
feature of tumor growth and recurrence it can be conceived that residual ameloblastoma cells acquire this survival mechanism to adapt to
their microenvironment and reactivate later (Almeida et al., 2016).
Tumor growth, progression and recurrence are orchestrated by
mechanistic processes that favor survival in an unfavorable environment. Cytoprotective autophagy is associated with resistance to therapy
of several oral-epithelial tumors (Huang & Liu, 2016; Lu & Xie, 2016).
Additionally, EP-AMCs compared to HODCs, ALCs and MX-MSCs displayed increased levels of both LC3II and MREG, an LC3 binding
partner required in a hybrid degradation process known as LC3-associated phagocytosis (LAP). Interestingly, stromal cells in ameloblastoma
(MS-AMCs) displayed much lower basal levels of autophagic proteins
relative to the epithelial-derived cells (EP-AMCs) (Fig. 3). EP-AMCs
transplanted into immunocompromised hosts regenerated folliculartype of solid multicystic ameloblastoma similar to the tissue of origin.
Immunologically, ameloblastoma xenografts also strongly expressed
both LC3 and p62 especially at the epithelial-mesenchymal advancing

3.3. EP-AMCs regenerated ameloblastoma-like odontogenic tissues in mouse
xenograft model
Among the diﬀerent cell types transplanted in vivo, only EP-AMCs
xenografts doubled in size within 4 weeks. Unlike other xenografts,
histological analysis of EP-AMCs tumor xenograft displayed ameloblastoma-like tumor (Fig. 4) with similar columnar ameloblast-like
cells, loose stellate reticulum-like cells and regions of cystic degeneration characteristic of SMA-f (Fig. 4).
3.4. EP-AMCs induced epithelial-mesenchymal transition and recreated
neoplastic odontogenic epithelium in vivo
Next, we probed the ameloblastoma-like tumor sections with antibodies to LC3 and p62. The epithelial-mesenchymal invaginations of
the odontogenic epithelium (Fig. 5A) were strongly reactive to LC3 and
p62 (Fig. 5B–C) suggestive of autophagy-related survival of EP-AMCs
and ameloblastoma-like tumor.
4. Discussion
Solid multicystic ameloblastoma (SMA) is the most common type of
ameloblastoma. Histologically, it displays the follicular, plexiform or
mixed follicular/plexiform arrangement of proliferating odontogenic
epithelium that extends into the stroma (Eﬃom et al., 2017). We successfully isolated EP-AMCs and MS-AMCs from follicular SMA (SMA-f)
64
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Fig. 3. Increased LC3II and MREG in EP-AMCs. Western blot immunoreactive bands (A) and quantitative analysis (panel B) of autophagic proteins p62, MREG,
LC3-I and LC3II demonstrate strong immunoreactivity by EP-AMCS relative to control cells [positive controls = ALCs and HODCs; negative control = MX-MSCs].
Accumulation of autophagic proteins was higher in EP-AMCs versus MS-AMCs isolated from ameloblastoma stroma and control cells. LC3II (p < 0.01), p62
(p < 0.01) and MREG (p < 0.05) were signiﬁcantly expressed in EP-AMCs relative to HODCs, another odontogenic cell population.

strongly expressed by EP-AMCs is a major signaling hub involved in
multiple signaling pathways and its high expression is associated with
poor prognosis of several epithelial cancers such as ovarian cancer
(Iwadate et al., 2014). Most ameloblastomas display genetic mutations
of BRAF that encodes the serine/threonine protein kinase B-Raf, an
activator of MAPK/ERK-signaling pathway(Eﬃom et al., 2017); and
ameloblastomas are associated with elevated levels of autophagic

edge that further supports a possible unique role for EP-AMC autophagy-associated pathways in ameloblastoma recurrence. Through canonical autophagy, intracellular substrates are enwrapped as cargo by
double membrane structures known as autophagosomes formed by the
actions of LC3. This allows for bulk turnover of cytoplasmic components, enabling among other functions, the survival of nutrient-deprived cells (Florey & Overholtzer, 2012). The autophagic protein p62

Fig. 4. In vivo recreation of ameloblastoma-like odontogenic tumor by EP-AMCs. Histological pattern of ameloblastoma (A) was recreated in a mouse tumor
xenograft model of subcutaneous transplant of EP-AMCs (B, C). The EP-AMCs tumor xenograft displayed similar columnar ameloblast-like cells (black arrow heads),
loose stellate reticulum-like cells (*) and regions of cystic degeneration (green arrows) characteristic of SMA-f.
65
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Fig. 5. Epithelial mesenchymal transition induced by EP-AMCs. Ameloblast-like tumor regenerated by EP-AMCs displayed stromal epithelial invagination (A,
black arrows) positive for LC3 (B, blue arrowheads) and p62 (C, green arrowheads) indicating autophagic processes.

markers, LC3, BECN1, and p62 (Okada et al., 2014). Additionally, BRAF
signaling and autophagy induce resistance to therapy in other tumors
such as melanoma, epithelial ovarian cancers and pancreatic cancers
(Iwadate et al., 2014; Yang et al., 2011).
Since high rates of cell death correlate with high mitotic index and
tumor aggressiveness, the tumor microenvironment at various stages
contains a population of dying cells (Lipponen, Aaltomaa, Kosma, &
Syrjanen, 1994; Liu, Edgerton, Moore, & Thor, 2001). These dying cells
serve as substrates for other phagocytic cells in a process known as
entosis. During entosis, cells are engulfed alive and mediate their own
internalization. Entosis may serve as a tumor suppressor (Florey, Kim,
Sandoval, Haynes, & Overholtzer, 2011) or may promote tumor progression in the long term (Krajcovic et al., 2011). In these studies, we
observe increased p62 levels, that suggests a decrease in canonical
autophagy due to defective autophagolysosomal degradative capacity.
Additionally, there was also an increase in both LC3B and its adapter
protein, MREG required in LAP. Ability of LAP to facilitate destruction
of cells corpses or cells stimulates anti-inﬂammatory mediators, hence
therapeutically, the Inhibition of LAP dependent processes could shift
the tumor microenvironment to one that is more pro-inﬂammatory or
tumoricidal. As diagrammatically summarized in Fig. 6, it is possible
that either decreased autophagolysosome capacity or increased LAP
could promote ameloblastoma recurrence.
Ameloblastoma recurrence is independent of histologic type although tumor microenvironment plays a determinant role in accelerating tumor growth and cancer reoccurrence after surgical resection
or chemotherapy (Hanahan & Coussens, 2012). One report has shown
that epithelial cells isolated from SMA-f can be induced by stromalderived IL-6 to promote expression of stem cell related genes and epithelial-mesenchymal transition (Jiang et al., 2017). The tumor microenvironment is usually hypoxic, and hypoxia-activated autophagy has
been associated with degradation of p62 in some cells, so interplay of
hypoxia and autophagy but not necessarily histologic variant possibly
plays a role in ameloblastoma survival. Phosphatidylserine-positive
(PS+) dying tumor or normal cells induce autophagy mediated degradation, often through LAP (Florey & Overholtzer, 2012). In LAP, LC3
is directly conjugated to a single membrane phagosome in a nutrientindependent manner (Martinez et al., 2011; Sanjuan et al., 2007). Two
components critical for LAP-mediated degradation of ingested PS+
components by epithelial cells are LC3 and its binding partner MREG
(Frost et al., 2015) both of which were upregulated in EP-AMCs. LAP
dependent degradation of ingested PS+ structures by epithelial cells
provides fuel for oxidative metabolism (Reyes-Reveles et al., 2017). It is
possible that residual ameloblastoma cells predisposed to LAP mediated
cargo degradation provide recycled bioenergetic cellular components
for survival and proliferation of residual ameloblastoma cells (Fig. 6).
Therefore, like other head and neck cancers (Almeida et al., 2016),
ameloblastoma possibly adapts dynamically to its microenvironment

Fig. 6. Proposed autophagy-mediated survival of ameloblastoma cells.
Engulfed residual ameloblastoma cells are phagocytosed to become intracellular substrates enwrapped by double membrane (autophagosomes) or
single membrane vesicles (LC3-associated phagocytosis [LAP]). Either loss of
autophagosome degradative capacity or LAP-mediated recycling of bioenergetic components allows for bulk turnover of cytoplasmic components that
enable survival of nutrient-deprived residual ameloblastoma cells.

using putative clonogenically active stem-like cells, hypoxia and autophagic process. Additional studies are underway to delineate how EPAMCs utilize autophagy associated process to promote ameloblastoma
recurrence.
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